HUMA Humacyte, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
00:26
Oct 30
Oct 30
r/wallstreetbets
Speculative healthcare holding, upside seen outweighing risk
The author lists Huma among their two very speculative healthcare holdings, calling it risky but viewing the possible positives as outweighing the potential negatives. No specific catalyst, product or financial mechanism is given beyond the speculative healthcare framing. Main stated risk is the speculative nature of the position.
HUMA
Humacyte, Inc.
Long
1ST
Position: Holding
—
01:55
Jan 22
Jan 22
r/pennystocks
FDA-approved biotech with dialysis catalyst, 5–10x upside
The author argues HUMA is undervalued near $1 with an FDA-approved product (Symvess) for vascular trauma and military injuries, plus DoD/BARDA backing. The upcoming dialysis access indication represents a multi-billion market, and positive Phase 3 data plus commercialization could drive a 5–10x re-rating. Main stated risks are biotech dilution and risk-off sentiment.
HUMA
Humacyte, Inc.
Long
1ST
—
—
About HUMA Investor Commentary
Across the available history and selected sources, Buzzberg tracks HUMA (Humacyte, Inc.) across 3 sources: 2 bullish vs 0 bearish calls from 3 authors. Historical directional balance: 67% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 3 total trade ideas tracked. Past 7 days, before deduplication: 1 other directions. Latest voices: u/TheBullRunKid, u/Rustic4748.